Furthermore, we were able to demonstrate synergistic anti‐neoplastic effects of JQ1 and BCR::ABL1 TKI in primary CML cells (Figure S8C). This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.